Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Congenital Abnormalities × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

fludarabine phosphate 32 Cytarabine 29 Cyclophosphamide 24 Whole-Body Irradiation 23 Peripheral Blood Stem Cell Transplantation 23 Mycophenolic Acid 22 Busulfan 21 Tacrolimus 19 Cyclosporine 15 Filgrastim 14 Etoposide 14 Antilymphocyte Serum 14 Methotrexate 13 Melphalan 11 Idarubicin 9 Granulocyte Colony-Stimulating Factor 9 Clofarabine 8 Mitoxantrone 7 Flow Cytometry 7 Sirolimus 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 aldesleukin 5 Vorinostat 5 Daunorubicin 5 thymoglobulin 4 fludarabine 4 alvocidib 4 Thiotepa 4 Polymerase Chain Reaction 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡